Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

Completed · Phase 3

Conditions studied: Breast Cancer

In brief

RATIONALE: 1. . To compare the effects on breast cancer of three different combinations of drugs which are commonly used to treat this disease. 2. . It is not yet known which treatment regimen is most effective for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy given with or without epoetin alfa in treating women who have undergone surgery for stage I, stage II, or stage III breast cancer.

Key facts

Study ID
NCT00014222
Run by
NCIC Clinical Trials Group
People needed
2104
Starts
2000-12-04
Expected to finish
2014-03-17
Last updated by the study team
2020-10-05

Who can join

Age: any, up to 60. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.